{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:13:16Z","timestamp":1789704796092,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd011646","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T00:00:00Z","timestamp":1490918400000}}],"reference-count":234,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011646.pub2","type":"journal-article","created":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T17:43:06Z","timestamp":1491241386000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease)"],"prefix":"10.1002","volume":"2017","author":[{"given":"Elena","family":"Buzzetti","sequence":"first","affiliation":[{"name":"Royal Free Hospital and the UCL Institute of Liver and Digestive Health; Sheila Sherlock Liver Centre; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kalafateli","sequence":"additional","affiliation":[{"name":"Royal Free Hospital and the UCL Institute of Liver and Digestive Health; Sheila Sherlock Liver Centre; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Thorburn","sequence":"additional","affiliation":[{"name":"Royal Free Hospital and the UCL Institute of Liver and Digestive Health; Sheila Sherlock Liver Centre; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R","family":"Davidson","sequence":"additional","affiliation":[{"name":"Royal Free Campus, UCL Medical School; Department of Surgery; Pond Street London UK NW3 2QG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Thiele","sequence":"additional","affiliation":[{"name":"Odense University Hospital; Department of Gastroenterology and Hepatology; Sdr. Boulevard 29, Entrance 126 Odense Denmark 5000"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise Lotte","family":"Gluud","sequence":"additional","affiliation":[{"name":"Copenhagen University Hospital Hvidovre; Gastrounit, Medical Division; Kettegaards Alle Hvidovre Denmark 2650"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Del Giovane","sequence":"additional","affiliation":[{"name":"University of Modena and Reggio Emilia; Cochrane Italy, Department of Diagnostic, Clinical and Public Health Medicine; Via del Pozzo 71 Modena Italy 41124"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gro","family":"Askgaard","sequence":"additional","affiliation":[{"name":"Rigshospitalet; Department of Hepatology; Blegdamsvej 9 K\u00f8benhavn \u00d8 Denmark 2100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Krag","sequence":"additional","affiliation":[{"name":"Odense University Hospital; Department of Gastroenterology and Hepatology; Sdr. Boulevard 29, indgang 126 Odense C Denmark 5000"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Tsochatzis","sequence":"additional","affiliation":[{"name":"Royal Free Hospital and the UCL Institute of Liver and Digestive Health; Sheila Sherlock Liver Centre; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurinchi Selvan","family":"Gurusamy","sequence":"additional","affiliation":[{"name":"Royal Free Campus, UCL Medical School; Department of Surgery; Pond Street London UK NW3 2QG"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,3,31]]},"reference":[{"key":"10.1002\/14651858.CD011646.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0016-5085(90)90973-5","article-title":"Failure of colchicine to improve short-term survival in patients with alcoholic hepatitis","volume":"99","author":"Akriviadis","year":"1990","journal-title":"Gastroenterology"},{"issue":"4 (Pt 2)","key":"10.1002\/14651858.CD011646.pub2-BIB0002|cit2","first-page":"250a","article-title":"Improved short-term survival with pentoxifylline treatment in severe acute alcoholic hepatitis","volume":"26","author":"Akriviadis","year":"1997","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/0016-5085(81)90250-X","article-title":"A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis: progress report in 50 patients","volume":"80","author":"Baker","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0005|cit5","first-page":"1284","article-title":"Randomized clinical trial of insulin and glucagon for alcoholic hepatitis","volume":"76","author":"Hatfield","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0006|cit6","first-page":"44","article-title":"Role of mycophenolate mofetil (mmf) in steroid non responsive severe acute alcoholic hepatitis: a randomized open label placebo control prospective clinical pilot trial","volume":"17","author":"Basu","year":"2015","journal-title":"HPB"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/hep.1840140625","article-title":"Insulin and glucagon infusion in acute alcoholic hepatitis: a prospective randomized controlled trial","volume":"14","author":"Bird","year":"1991","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0168-8278(88)80005-9","article-title":"Randomised controlled double-blind trial of the calcium channel antagonist amlodipine in the treatment of acute alcoholic hepatitis","volume":"28","author":"Bird","year":"1998","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD011646.pub2-BIB0009|cit9","first-page":"880","article-title":"Adrenocorticosteroid therapy in alcoholic hepatitis - prospective, double-blind, randomized study","volume":"64","author":"Blitzer","year":"1973","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF01072499","article-title":"Adrenocorticosteroid therapy in alcoholic hepatitis. A prospective, double blind randomized study","volume":"22","author":"Blitzer","year":"1977","journal-title":"American Journal of Digestive Diseases"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1053\/j.gastro.2008.08.057","article-title":"A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis","volume":"135","author":"Boetticher","year":"2008","journal-title":"Gastroenterology"},{"issue":"16","key":"10.1002\/14651858.CD011646.pub2-BIB0012|cit12","first-page":"769","article-title":"Treatment of acute alcoholic hepatitis with prednisolone. 45 patients","volume":"16","author":"Bories","year":"1987","journal-title":"Presse Medicale"},{"issue":"4 (Pt 2)","key":"10.1002\/14651858.CD011646.pub2-BIB0014|cit13","first-page":"444a","article-title":"Metadoxine in the treatment of alcoholic fatty liver a randomized multicenter trial","volume":"24","author":"Caballeria","year":"1996","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0013|cit14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0168-8278(98)80202-X","article-title":"Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial. Spanish Group for the Study of Alcoholic Fatty Liver","volume":"28","author":"Caballeria","year":"1998","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD011646.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7326\/0003-4819-79-5-625","article-title":"Prednisone therapy of acute alcoholic hepatitis. Report of a controlled trial","volume":"79","author":"Campra","year":"1973","journal-title":"Annals of Internal Medicine"},{"issue":"9","key":"10.1002\/14651858.CD011646.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial","volume":"110","author":"Carithers","year":"1989","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0017|cit17","first-page":"1202","article-title":"Prednisolone therapy in patients with severe alcoholic hepatitis: results of a multicenter trial","volume":"6","author":"Maddrey","year":"1986","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0018|cit18","first-page":"510A","article-title":"The natural history of alcoholic cirrhosis: effect of colchicine","volume":"28","author":"Colman","year":"1998","journal-title":"Hepatology"},{"issue":"4 (Pt 2)","key":"10.1002\/14651858.CD011646.pub2-BIB0019|cit19","first-page":"423a","article-title":"Lack of effect of colchicine in alcoholic cirrhosis: Final results of a double-blind randomized trial","volume":"32","author":"Cortez Pinto","year":"2000","journal-title":"Hepatology"},{"issue":"2 (Pt 2)","key":"10.1002\/14651858.CD011646.pub2-BIB0020|cit20","first-page":"229a","article-title":"Colchicine in alcoholic cirrhosis - preliminary results of a double-blind randomized trial","volume":"16","author":"Cortez Pinto","year":"1992","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00042737-200204000-00007","article-title":"Lack of effect of colchicine in alcoholic cirrhosis: final results of a double blind randomized trial","volume":"14","author":"Cortez-Pinto","year":"2002","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"13","key":"10.1002\/14651858.CD011646.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3748\/wjg.15.1613","article-title":"Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial","volume":"15","author":"De","year":"2009","journal-title":"World Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD011646.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"810","DOI":"10.4103\/2141-9248.141562","article-title":"Pentoxifylline plus prednisolone versus pentoxifylline only for severe alcoholic hepatitis: a randomized controlled clinical trial","volume":"4","author":"De","year":"2014","journal-title":"Annals of Medical and Health Sciences Research"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/07315724.1995.10718493","article-title":"Effects of long-term vitamin E supplementation in alcoholic cirrhotics","volume":"14","author":"Maza","year":"1995","journal-title":"Journal of the American College of Nutrition"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0016-5085(80)90867-7","article-title":"Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy","volume":"78","author":"Depew","year":"1980","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD011646.pub2-BIB0026|cit26","first-page":"A150","article-title":"Double-blind controlled trial of corticosteroid-therapy in severe alcoholic hepatitis with encephalopathy","volume":"26","author":"Depew","year":"1978","journal-title":"Clinical Research"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-8741(02)00263-5","article-title":"Liv.52 in alcoholic liver disease: a prospective, controlled trial","volume":"84","author":"Silva","year":"2003","journal-title":"Journal of Ethnopharmacology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0028|cit28","first-page":"9","article-title":"Parenteral S-adenosylmethionine compared to placebos in the treatment of alcoholic liver diseases","volume":"13","author":"Diaz Belmont","year":"1996","journal-title":"Anales de Medicina Interna"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0029|cit29","first-page":"2723","article-title":"Liver-protective action of silymarin therapy in chronic alcoholic liver diseases","volume":"130","author":"Feher","year":"1989","journal-title":"Orvosi Hetilap"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"738","DOI":"10.7326\/0003-4819-65-4-738","article-title":"The non efficacy of short-term anabolic steroid therapy in alcoholic liver disease","volume":"65","author":"Fenster","year":"1966","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0032|cit31","first-page":"481","article-title":"Effect of pentoxifylline on survival, cardiac function and both portal and systemic hemodynamics in advanced alcoholic cirrhosis-a randomized double-blind placebo-controlled trial","volume":"100","author":"Fernandez-Rodriguez","year":"2008","journal-title":"Revista Espanola de Enfermedades Digestivas"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011646.pub2-BIB0031|cit32","first-page":"80","article-title":"Pentoxifylline ameliorates vasodilation and left ventricular function in alcoholic cirrhosis","volume":"42","author":"Fernandez-Rodriguez","year":"2005","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0034|cit33","first-page":"100","article-title":"The ayurvedic medicine LIV.52 in alcoholic cirrhosis of the liver: Results of a prospective, randomised, double-blind, placebo-controlled, clinical study","volume":"36","author":"Fleig","year":"1998","journal-title":"Zeitschrift fur Gastroenterologie"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011646.pub2-BIB0033|cit34","first-page":"S127","article-title":"The ayurvedic drug Liv52 in patients with alcoholic cirrhosis results of a prospective, randomized, doubleblind, placebo-controlled clinical trial","volume":"26","author":"Fleig","year":"1997","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD011646.pub2-BIB0035|cit35","first-page":"227","article-title":"Pentoxifylline versus steroid in short-term survival in severe acute alcoholic hepatitis","volume":"28","author":"Garrido Garcia","year":"2012","journal-title":"Medicina Interna de M\u00e9xico"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0036|cit36","first-page":"449","article-title":"Effect of cycloxilic acid administration on ethanol-induced hepatic steatosis. Controlled clinical trial","volume":"34","author":"Geminiani","year":"1979","journal-title":"Farmaco - Edizione Pratica"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011646.pub2-BIB0037|cit37","first-page":"S59","article-title":"Effect of testosterone treatment in men with alcoholic cirrhosis","volume":"1","author":"Gluud","year":"1985","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD011646.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hep.1840060502","article-title":"Testosterone treatment of men with alcoholic cirrhosis: a double-blind study. The Copenhagen Study Group for Liver Diseases","volume":"6","author":"The Copenhagen Study Group for Liver Diseases","year":"1986","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0016-5085(82)80257-6","article-title":"Double-blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis","volume":"82","author":"Halle","year":"1982","journal-title":"Gastroenterology"},{"issue":"5 (Pt 2)","key":"10.1002\/14651858.CD011646.pub2-BIB0040|cit40","first-page":"1024","article-title":"Propylthiouracil therapy in severe acute alcoholic hepatitis","volume":"79","author":"Halle","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7326\/0003-4819-74-3-311","article-title":"Alcoholic hepatitis. Natural history and evaluation of prednisolone therapy","volume":"74","author":"Helman","year":"1971","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1665-2681(19)30863-4","article-title":"Treatment with metadoxine and its impact on early mortality in patients with severe alcoholic hepatitis","volume":"13","author":"Higuera-de la Tijera","year":"2014","journal-title":"Annals of Hepatology"},{"issue":"16","key":"10.1002\/14651858.CD011646.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.3748\/wjg.v21.i16.4975","article-title":"Metadoxine improves the three- and six-month survival rates in patients with severe alcoholic hepatitis","volume":"21","author":"Higuera-de la Tijera","year":"2015","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0168-8278(05)80489-1","article-title":"The prognosis of patients with alcoholic liver disease. An international randomized, placebo-controlled trial on the effect of malotilate on survival","volume":"20","author":"Keiding","year":"1994","journal-title":"Journal of Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD011646.pub2-BIB0045|cit45","first-page":"419","article-title":"Malotilate in alcoholic liver disease a randomized, double-blind, international trial of the effect of long-term treatment on survival","volume":"12","author":"Keiding","year":"1990","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0046|cit46","first-page":"812A","article-title":"The beneficial effect of angiotensin-blocking agent on liver fibrosis in patients with alcoholic liver disease: a randomized controlled trial","volume":"50","author":"Kim","year":"2009","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1478-3231.2012.02774.x","article-title":"Beneficial effects of candesartan, an angiotensin-blocking agent, on compensated alcoholic liver fibrosis - a randomized open-label controlled study","volume":"32","author":"Kim","year":"2012","journal-title":"Liver International"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"S378","DOI":"10.1016\/S0168-8278(09)61045-X","article-title":"Pentoxifylline (PTX) reduces the risk of complications in patients with advanced cirrhosis. Analysis of the results of a pivotal phase 3 trial","volume":"50","author":"Lebrec","year":"2009","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1053\/j.gastro.2010.01.040","article-title":"Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis","volume":"138","author":"Lebrec","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0050|cit50","first-page":"12","article-title":"LIV. 52 in patients with alcoholic liver cirrhosis - pilot study of a controlled clinical trial","volume":"2","author":"Lotterer","year":"1995","journal-title":"Forschende Komplement\u00e4rmedizin"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5414\/CPP40002","article-title":"Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis","volume":"40","author":"Lucena","year":"2002","journal-title":"International Journal of Clinical Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"S533","DOI":"10.1016\/S0168-8278(12)61368-3","article-title":"Pentoxifylline does not improve short-term survival in severe alcoholic hepatitis in combination with corticosteroids: results of a randomized controlled trial","volume":"56","author":"Louvet","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2013.276300","article-title":"Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial","volume":"310","author":"Mathurin","year":"2013","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0168-8278(99)80263-3","article-title":"S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial","volume":"30","author":"Mato","year":"1999","journal-title":"Journal of Hepatology"},{"issue":"4 (Pt 2)","key":"10.1002\/14651858.CD011646.pub2-BIB0056|cit56","first-page":"251a","article-title":"S-adenosylmethionine in the treatment of alcoholic liver cirrhosis: Results from a multicentric placebo-controlled, randomized, double-blind clinical trial","volume":"26","author":"Mato","year":"1997","journal-title":"Hepatology"},{"issue":"Suppl S4","key":"10.1002\/14651858.CD011646.pub2-BIB0057|cit57","first-page":"96A","article-title":"Pentoxyfylline may prevent renal impairment (hepatorenal syndrome) in severe acute alcoholic hepatitis","volume":"14","author":"McHutchinson","year":"1991","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1111\/j.1530-0277.2011.01547.x","article-title":"S-adenosyl-L-methionine treatment for alcoholic liver disease: a double-blinded, randomized, placebo-controlled trial","volume":"35","author":"Medici","year":"2011","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"5","key":"10.1002\/14651858.CD011646.pub2-BIB0060|cit59","first-page":"850","article-title":"Survival after steroid treatment (T) for alcoholic hepatitis (AH)","volume":"3","author":"Mendenhall","year":"1983","journal-title":"Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD011646.pub2-BIB0059|cit60","first-page":"A","article-title":"Risk factors and therapy in alcoholic hepatitis (AH)","volume":"72","author":"Mendenhall","year":"1977","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM198412063112302","article-title":"Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone","volume":"311","author":"Mendenhall","year":"1984","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0168-8278(03)00476-8","article-title":"A randomized placebo controlled trial of vitamin E for alcoholic hepatitis","volume":"40","author":"Mezey","year":"2004","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD011646.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"264A","DOI":"10.1016\/S0270-9139(03)80268-9","article-title":"A randomized placebo controlled trial of vitamin E in alcoholic hepatitis","volume":"38","author":"Mezey","year":"2003","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0064|cit64","first-page":"36","article-title":"A randomized clinical trial of insulin and glucagon infusion for treatment of severe acute alcoholic hepatitis: Report in 26 patients","volume":"17","author":"Mirouze","year":"1982","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"S366","DOI":"10.1016\/S0168-8278(09)61012-6","article-title":"Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized, multicenter, controlled trial","volume":"50","author":"Moreno","year":"2009","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD011646.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jhep.2010.05.030","article-title":"Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial","volume":"53","author":"Moreno","year":"2010","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD011646.pub2-BIB0067|cit67","first-page":"A641","article-title":"Colchicine does not prolong life in patients with advanced alcoholic cirrhosis: Results of a prospective, randomized, placebo-controlled, multicenter VA trial (CSP 352)","volume":"122","author":"Morgan","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1053\/j.gastro.2005.01.057","article-title":"Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival","volume":"128","author":"Morgan","year":"2005","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD011646.pub2-BIB0069|cit69","first-page":"A692","article-title":"A double blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"126","author":"Naveau","year":"2004","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD011646.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology"},{"issue":"4 (Suppl)","key":"10.1002\/14651858.CD011646.pub2-BIB0071|cit71","first-page":"346a","article-title":"Treatment of severe acute alcoholic hepatitis (AAH) with corticoids plus N-acetyl cysteine (C+NAC) versus corticoids alone (C): a multicentre, randomized, controlled trial","volume":"50","author":"Nguyen-Khac","year":"2009","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(10)60085-2","article-title":"Treatment of severe acute alcoholic hepatitis (AAH) with corticoids plus N-acetyl cysteine (C+NAC) versus corticoids alone (C): a multicentre, randomized, controlled trial","volume":"52","author":"Nguyen-Khac","year":"2010","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0016-5085(79)80136-5","article-title":"Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease","volume":"76","author":"Orrego","year":"1979","journal-title":"Gastroenterology"},{"issue":"8590","key":"10.1002\/14651858.CD011646.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0140-6736(88)91649-2","article-title":"Long-term treatment of alcoholic liver disease with propylthiouracil","volume":"1","author":"Orrego","year":"1988","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1056\/NEJM198712033172301","article-title":"Long-term treatment of alcoholic liver disease with propylthiouracil","volume":"317","author":"Orrego","year":"1987","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011646.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0168-8278(94)80005-7","article-title":"Long-term treatment of alcoholic liver disease with propylthiouracil. Part 2: influence of drop-out rates and of continued alcohol consumption in a clinical trial","volume":"20","author":"Orrego","year":"1994","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0078|cit78","first-page":"A459","article-title":"Role of pentoxifylline in treatment of severe acute alcoholic hepatitis - a randomized controlled trial","volume":"21","author":"Paladugu","year":"2006","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0168-8278(98)80285-7","article-title":"Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial","volume":"28","author":"Pares","year":"1998","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1016\/S0168-8278(13)60538-3","article-title":"Short-term survival in patients with severe alcoholic hepatitis treated with pentoxifylline vs. corticosteroid: a non-inferiority trial - a preliminary report","volume":"58","author":"Kim","year":"2013","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jhep.2014.05.014","article-title":"Pentoxifylline vs. corticosteroid to treat severe alcoholic hepatitis: a randomised, non-inferiority, open trial","volume":"61","author":"Park","year":"2014","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1053\/jhep.2003.50118","article-title":"A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice","volume":"37","author":"Pelletier","year":"2003","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jhep.2005.11.039","article-title":"Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis-a randomised clinical trial","volume":"44","author":"Phillips","year":"2006","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD011646.pub2-BIB0084|cit84","first-page":"250A","article-title":"Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis: a randomized trial","volume":"34","author":"Phillips","year":"2001","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0085|cit85","first-page":"527","article-title":"Epomediol treatment of fatty liver in alcohol abuse. A controlled clinical double-blind study","volume":"112","author":"Pierri","year":"1985","journal-title":"Clinica Terapeutica"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0086|cit86","first-page":"653","article-title":"Ursodeoxycholic acid in the treatment of alcoholic liver-disease","volume":"3","author":"Plevris","year":"1991","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD011646.pub2-BIB0087|cit87","first-page":"S7","article-title":"Ursodeoxycholic acid in the treatment of alcoholic liver disease","volume":"34","author":"Plevris","year":"1993","journal-title":"Gut"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.1016\/S0168-8278(09)61022-9","article-title":"Improved survival in patients with advanced alcoholic hepatitis (AAH) with a combined treatment associating a non-absorbable antibiotic rifaximin to corticoids plus ursodeoxicholic acid (UDCA)","volume":"50","author":"Popescu","year":"2009","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM197106172842404","article-title":"Corticosteroid therapy in severe alcoholic hepatitis - double-blind drug trial","volume":"284","author":"Porter","year":"1971","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0090|cit90","first-page":"322","article-title":"Management of acute alcoholic hepatitis with insulin and glucagon infusion","volume":"13","author":"Radvan","year":"1983","journal-title":"Australian and New Zealand Journal of Medicine"},{"issue":"2 bis","key":"10.1002\/14651858.CD011646.pub2-BIB0091|cit91","first-page":"A4","article-title":"[corticotherapy improves short-term survival in patients with severe acute alcoholic hepatitis. A bicenter double-blind randomized study]","volume":"15","author":"Ramond","year":"1991","journal-title":"Gastroenterologie Clinique Et Biologique"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM199202203260802","article-title":"A randomized trial of prednisolone in patients with severe alcoholic hepatitis","volume":"326","author":"Ramond","year":"1992","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011646.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/0168-8278(91)91241-8","article-title":"Prednisolone markedly improves short-term survival of patients with severe biopsy-proven alcoholic hepatitis a double blind randomized bicenter trial","volume":"13","author":"Ramond","year":"1991","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000197590","article-title":"Preliminary observations of d-penicillamine therapy in acute alcoholic liver disease","volume":"11","author":"Resnick","year":"1974","journal-title":"Digestion"},{"issue":"2 (Pt 2)","key":"10.1002\/14651858.CD011646.pub2-BIB0095|cit95","first-page":"234a","article-title":"Corticosteroids (Cs) does not influence plasma tumor necrosis factor-alpha (pTNF) and interleukin 6 (pIl6) concentrations in severe alcoholic hepatitis (AH): a cross over study","volume":"16","author":"Mal","year":"1992","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011646.pub2-BIB0096|cit96","first-page":"S75","article-title":"Influence of corticosteroids (Cs) on plasma cytokines concentrations in patients with severe alcoholic hepatitis (HA): Results of a randomized study","volume":"18","author":"Richardet","year":"1993","journal-title":"Journal of Hepatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011646.pub2-BIB0097|cit97","first-page":"S64","article-title":"Colchicine treatment in alcoholic liver disease. A controlled and randomized study","volume":"16","author":"Sainz","year":"1992","journal-title":"Journal of Hepatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011646.pub2-BIB0098|cit98","first-page":"S124","article-title":"Silymarin treatment in alcoholic liver disease: a double blind randomized trial","volume":"1","author":"Salvaqnini","year":"1985","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0099|cit99","first-page":"194","article-title":"Treatment of severe alcoholic hepatitis with propythiouracil (PTU)","volume":"76","author":"Serrano-Cancino","year":"1981","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0100|cit100","first-page":"443","article-title":"A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis. With a note on published results in encephalopathic patients","volume":"69","author":"Shumaker","year":"1978","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"S306","DOI":"10.1016\/S0168-8278(10)60789-1","article-title":"A prospective randomised trial to compare the efficacy of corticosteroids plus pentoxifylline versus corticosteroids alone in the treatment of severe alcoholic hepatitis","volume":"52","author":"Sidhu","year":"2010","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1007\/s10620-012-2097-4","article-title":"Corticosteroid plus pentoxifylline is not better than corticosteroid alone for improving survival in severe alcoholic hepatitis (COPE trial)","volume":"57","author":"Sidhu","year":"2012","journal-title":"Digestive Diseases & Sciences"},{"issue":"4 (Suppl 1)","key":"10.1002\/14651858.CD011646.pub2-BIB0103|cit103","first-page":"373a","article-title":"Pentoxifylline reduces disease severity and prevents renal impairment in severe acute alcoholic hepatitis: a double blind, placebo controlled trial","volume":"44","author":"Sidhu","year":"2006","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0104|cit104","first-page":"20","article-title":"Pentoxifylline in severe alcoholic hepatitis: a prospective, randomised trial","volume":"60","author":"Sidhu","year":"2012","journal-title":"Journal of the Association of Physicians of India"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/ajg.2014.154","article-title":"Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study","volume":"109","author":"Singh","year":"2014","journal-title":"American Journal of Gastroenterology"},{"issue":"5 suppl. 1","key":"10.1002\/14651858.CD011646.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"S1004","DOI":"10.1016\/S0016-5085(13)63730-0","article-title":"Granulocyte-colony stimulating factor (G-CSF) in alcoholic hepatitis: a randomized controlled trial","volume":"144","author":"Singh","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0168-8278(02)00230-1","article-title":"Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study","volume":"37","author":"Spahr","year":"2002","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"17p","DOI":"10.1042\/cs098017P","article-title":"Effect of UDCA on fibrosis markers in alcoholic liver disease","volume":"98","author":"Stenner","year":"2000","journal-title":"Clinical science"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhep.2007.03.027","article-title":"A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis","volume":"47","author":"Stewart","year":"2007","journal-title":"Journal of Hepatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011646.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0168-8278(02)80041-1","article-title":"A trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis","volume":"36","author":"Stewart","year":"2002","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0111|cit111","first-page":"741A","article-title":"G-CSF mobilization of bone marrow-derived hepatocyte and haematopoietic progenitors in acute alcoholic hepatitis - a randomised controlled trial. Preliminary data","volume":"42","author":"Stigliano","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD011646.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0741-8329(89)90021-9","article-title":"Effects of malotilate treatment on alcoholic liver disease","volume":"6","author":"Takase","year":"1989","journal-title":"Alcohol"},{"issue":"6","key":"10.1002\/14651858.CD011646.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/BF02782949","article-title":"Effects of malotilate treatment on the serum markers of hepatic fibrogenesis in liver cirrhosis","volume":"23","author":"Takase","year":"1988 Dec","journal-title":"Gastroenterologia Japonica"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/gut.23.1.75","article-title":"Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis","volume":"23","author":"Theodossi","year":"1982","journal-title":"Gut"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/1745-6215-14-262","article-title":"Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial","volume":"14","author":"Forrest","year":"2013","journal-title":"Trials"},{"issue":"102","key":"10.1002\/14651858.CD011646.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta191020","article-title":"The clinical effectiveness and cost-effectiveness of steroids or pentoxifylline for alcoholic hepatitis (STOPAH): a 2x2 factorial randomised controlled trial","volume":"19","author":"Thursz","year":"2015","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"2 suppl. 1","key":"10.1002\/14651858.CD011646.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"S239","DOI":"10.1016\/S0168-8278(16)00238-5","article-title":"Prednisolone plus S-adenosylmethionine in severe alcoholic hepatitis","volume":"64","author":"Tkachenko","year":"2016","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD011646.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s12072-016-9751-4","article-title":"Prednisolone plus S-adenosil-L-methionine in severe alcoholic hepatitis","volume":"10","author":"Tkachenko","year":"2016","journal-title":"Hepatology International"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0120|cit120","first-page":"551","article-title":"Treatment of alcoholic hepatitis with colchicine. Results of a randomized double blind trial","volume":"13","author":"Trinchet","year":"1989","journal-title":"Gastroenterologie Clinique et Biologique"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011646.pub2-BIB0121|cit121","first-page":"S142","article-title":"Treatment of active alcoholic liver disease (AADL) by colchicine: Results of a 6 months double blind trial","volume":"1","author":"Trinchet","year":"1985","journal-title":"Journal of Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD011646.pub2-BIB0122|cit122","first-page":"103a","article-title":"Treatment of alcoholic hepatitis with colchicine. Preliminary results of a double blind study in 46 patients","volume":"7","author":"Trinchet","year":"1983","journal-title":"Gastroenterologie Clinique Et Biologique"},{"issue":"2 bis","key":"10.1002\/14651858.CD011646.pub2-BIB0123|cit123","first-page":"167a","article-title":"Treatment of alcoholic hepatitis by silymarine, a double blind multicenter study in 116 patients","volume":"11","author":"Trinchet","year":"1987","journal-title":"Gastroenterologie Clinique Et Biologique"},{"issue":"2","key":"10.1002\/14651858.CD011646.pub2-BIB0124|cit124","first-page":"120","article-title":"A randomized double blind trial of silymarin in 116 patients with alcoholic hepatitis","volume":"13","author":"Trinchet","year":"1989","journal-title":"Gastroenterologie Clinique Et Biologique"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011646.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/0168-8278(90)91585-K","article-title":"Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon a multicentre sequential trial","volume":"11","author":"Trinchet","year":"1990","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/hep.1840150115","article-title":"Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: a multicenter sequential trial","volume":"15","author":"Trinchet","year":"1992","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0168-8278(97)80255-3","article-title":"Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients","volume":"26","author":"Velussi","year":"1997","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD011646.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0011-393X(05)80660-5","article-title":"Silymarin reduces hyperinsulinemia, malondialdehyde levels, and daily insulin need in cirrhotic diabetic patients","volume":"53","author":"Velussi","year":"1993","journal-title":"Current Therapeutic Research - Clinical and Experimental"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0129|cit129","first-page":"871","article-title":"A prospective randomized clinical trial of peripheral amino acid-glucose supplementation in acute alcoholic hepatitis","volume":"82","author":"Achord","year":"1987","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0130|cit130","first-page":"615","article-title":"Nutritional support in hospitalized patients with alcoholic liver disease","volume":"43","author":"Bunout","year":"1989","journal-title":"European Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/jhep.2000.8627","article-title":"Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial","volume":"32","author":"Cabre","year":"2000","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-8278(85)80762-5","article-title":"Controlled trial of nutritional supplementation, with and without branched chain amino acid enrichment, in treatment of acute alcoholic hepatitis","volume":"1","author":"Calvey","year":"1985","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD011646.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/hep.1840120331","article-title":"Corticosteroid therapy of alcoholic hepatitis: How many studies will it take?","volume":"12","author":"Carithers","year":"1990","journal-title":"Hepatology"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD011646.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0016-5085(78)90814-4","article-title":"Steroid treatment of alcoholic hepatitis. The yeas and the nays","volume":"74","author":"Conn","year":"1978","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD011646.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJMc1506342","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"373","author":"DiNubile","year":"2015","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1365-2036.2012.05075.x","article-title":"Randomised clinical trial: enteral nutrition does not improve the long-term outcome of alcoholic cirrhotic patients with jaundice","volume":"35","author":"Dupont","year":"2012","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD011646.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/flgastro-2015-100615","article-title":"Pentoxifylline is ineffective in treating severe alcoholic hepatitis","volume":"7","author":"Hendy","year":"2016","journal-title":"Frontline Gastroenterology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/0148607193017002119","article-title":"Controlled trial on nutrition supplementation in outpatients with symptomatic alcoholic cirrhosis","volume":"17","author":"Hirsch","year":"1993","journal-title":"JPEN. Journal of Parenteral and Enteral Nutrition"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0016-5085(92)91801-A","article-title":"Accelerated improvement of alcoholic liver disease with enteral nutrition","volume":"102","author":"Kearns","year":"1992","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD011646.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5455\/njppp.2016.6.27012016125","article-title":"Vitamin e improves quality of life in patients with alcoholic liver disease","volume":"6","author":"Kolasani","year":"2016","journal-title":"National Journal of Physiology, Pharmacy and Pharmacology"},{"issue":"3","key":"10.1002\/14651858.CD011646.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4103\/2231-0738.184582","article-title":"Efficacy of vitamin e supplementation in patients with alcoholic liver disease: an open-label, prospective, randomized comparative study","volume":"6","author":"Kolasani","year":"2016","journal-title":"International Journal of Nutrition, Pharmacology, Neurological Diseases"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0016-5085(78)90790-4","article-title":"Treatment of alcoholic hepatitis with encephalopathy. Comparison of prednisolone with caloric supplements","volume":"74","author":"Lesesne","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0143|cit143","first-page":"471","article-title":"Efficacy comparison between bicyclol and polyene phosphatidylcholine treatments for alcoholic liver disease","volume":"19","author":"Ma","year":"2011","journal-title":"Chung Hua Kan Tsang Ping Tsa Chih"},{"issue":"4 (Pt 2)","key":"10.1002\/14651858.CD011646.pub2-BIB0144|cit144","first-page":"319a","article-title":"Long term survival and prognostic factors in patients with severe biopsy-proved alcoholic hepatitis (ah) treated by prednisolone: Randomized trial, new cohort and simulation","volume":"20","author":"Mathurin","year":"1994","journal-title":"Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD011646.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1053\/gast.1996.v110.pm8964410","article-title":"Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone","volume":"110","author":"Mathurin","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.1840140624","article-title":"Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: a randomized controlled trial","volume":"14","author":"Mezey","year":"1991","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011646.pub2-BIB0147|cit147","first-page":"269A","article-title":"Impact of intensive enteral nutrition in association with corticosteroids in the treatment of severe alcoholic hepatitis: a multicenter randomized controlled trial","volume":"60","author":"Moreno","year":"2014","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0140-6736(80)92338-7","article-title":"Aminoacid therapy of alcoholic hepatitis","volume":"2","author":"Nasrallah","year":"1980","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/hep.1840060219","article-title":"A randomized clinical trial of supplementary parenteral nutrition in jaundiced alcoholic cirrhotic patients","volume":"6","author":"Naveau","year":"1986","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0150|cit150","first-page":"351","article-title":"Polyunsaturated phosphatidyl choline for acute alcoholic hepatitis: a double-blind, randomized, placebo-controlled trial","volume":"2","author":"Panos","year":"1990","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"9","key":"10.1002\/14651858.CD011646.pub2-BIB0151|cit151","first-page":"1219","article-title":"Steroids in alcoholic hepatitis: another salvo of data","volume":"87","author":"Ramond","year":"1992","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1016\/S0168-8278(11)60508-4","article-title":"Polyunsaturated phosphatidylcholine reduces insulin resistance and hepatic fibrosis in patients with alcoholic liver disease. results of randomized blinded prospective clinical study","volume":"54","author":"Sas","year":"2011","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0168-8278(88)80483-5","article-title":"A randomized controlled study of peripheral parenteral nutrition in moderate and severe alcoholic hepatitis","volume":"7","author":"Simon","year":"1988","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD011646.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/hep.22317","article-title":"Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial","volume":"48","author":"Spahr","year":"2008","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD011646.pub2-BIB0155|cit155","first-page":"282","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"373","author":"Thursz","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011646.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJMc1506342","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"373","author":"Verbeke","year":"2015","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0157|cit157","first-page":"490","article-title":"Alcohol-induced toxic hepatitis-a \"free radical\" associated disease. Lowering fatality by adjuvant antioxidant therapy","volume":"48","author":"Wenzel","year":"1993","journal-title":"Zeitschrift f\u00fcr die gesamte Innere Medizin und ihre Grenzgebiete"},{"issue":"10","key":"10.1002\/14651858.CD011646.pub2-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/ptr.3207","article-title":"Milk thistle in liver diseases: past, present, future","volume":"24","author":"Abenavoli","year":"2010","journal-title":"Phytotherapy Research"},{"issue":"5","key":"10.1002\/14651858.CD011646.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jhep.2012.04.041","article-title":"S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility","volume":"57","author":"Anstee","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0160|cit160","unstructured":"Blachier M Leleu H Peck-Radosavljevic M Valla DC Roudot-Thoraval F The burden of liver disease in Europe - a review of available epidemiological data, 2013 www.easl.eu\/assets\/application\/files\/54ae845caec619f_file.pdf"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0161|cit161","unstructured":"British Liver Trust Alcohol, 2014 www.britishlivertrust.org.uk\/liver-information\/liver-conditions\/alcohol\/"},{"issue":"2","key":"10.1002\/14651858.CD011646.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jrsm.57","article-title":"Using network meta-analysis to evaluate the existence of small-study effects in a network of interventions","volume":"3","author":"Chaimani","year":"2012","journal-title":"Research Synthesis Methods"},{"issue":"10","key":"10.1002\/14651858.CD011646.pub2-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PloS One"},{"issue":"3","key":"10.1002\/14651858.CD011646.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 statement: defining standard protocol items for clinical trials","volume":"158","author":"Chan","year":"2013","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011646.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD011646.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"e63509","DOI":"10.1371\/journal.pone.0063509","article-title":"Efficacy of new generation antidepressants: differences seem illusory","volume":"8","author":"Re","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1002\/14651858.CD011646.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780060325","article-title":"Methods for combining randomized clinical trials: strengths and limitations","volume":"6","author":"DeMets","year":"1987","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011646.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"7-8","key":"10.1002\/14651858.CD011646.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0170|cit170","unstructured":"Dias S Sutton AJ Welton NJ Ades AE NICE DSU Technical Support Document 3: heterogeneity: subgroups, meta-regression, bias and bias-adjustment, September 2011 (last updated April 2012) www.nicedsu.org.uk\/TSD3%20Heterogeneity.final%20report.08.05.12.pdf"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0171|cit171","unstructured":"Dias S Welton NJ Sutton AJ Ades AE NICE DSU Technical Support Document 1: introduction to evidence synthesis for decision making, April 2011 (last updated April 2012) www.nicedsu.org.uk\/TSD1%20Introduction.final.08.05.12.pdf"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0172|cit172","unstructured":"Dias S Welton NJ Sutton AJ Ades AE NICE DSU technical support document 2: a generalised linear modelling framework for pair wise and network meta-analysis of randomised controlled trials, August 2011 (last updated April 2014) www.nicedsu.org.uk\/TSD2%20General%20meta%20analysis%20corrected%2015April2014.pdf"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0173|cit173","unstructured":"Dias S Welton NJ Sutton AJ Caldwell DM Lu G Ades AE NICE DSU Technical Support Document 4: inconsistency in networks of evidence based on randomised controlled trials, May 2011 (last updated April 2014) www.nicedsu.org.uk\/TSD4%20Inconsistency.final.15April2014.pdf"},{"issue":"4","key":"10.1002\/14651858.CD011646.pub2-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/SLA.0b013e3181f5f23a","article-title":"Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors","volume":"252","author":"Duffy","year":"2010","journal-title":"Annals of Surgery"},{"issue":"2","key":"10.1002\/14651858.CD011646.pub2-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2012.04.004","article-title":"EASL clinical practical guidelines: management of alcoholic liver disease","volume":"57","author":"European Association for Study of Liver","year":"2012","journal-title":"Journal of Hepatology"},{"issue":"7109","key":"10.1002\/14651858.CD011646.pub2-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0177|cit177","unstructured":"EuroQol About EQ-5D www.euroqol.org\/about-eq-5d.html"},{"issue":"6","key":"10.1002\/14651858.CD011646.pub2-BIB0178|cit178","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002800.pub3","article-title":"Propylthiouracil for alcoholic liver disease","author":"Fede","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD011646.pub2-BIB0179|cit179","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005032.pub2","article-title":"Alcoholics Anonymous and other 12-step programmes for alcohol dependence","author":"Ferri","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD011646.pub2-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: pathogenesis and new therapeutic targets","volume":"141","author":"Gao","year":"2011","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD011646.pub2-BIB0181|cit181","first-page":"564","article-title":"Testosterone and alcoholic cirrhosis. Epidemiologic, pathophysiologic and therapeutic studies in men","volume":"35","author":"Gluud","year":"1988","journal-title":"Danish Medical Bulletin"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0182|cit182","unstructured":"Gluud C Nikolova D Klingenberg SL Cochrane Hepato-Biliary Group About Cochrane (Cochrane Review Groups (CRGs)) 2016, Issue 10. Art. No.: LIVER"},{"issue":"4","key":"10.1002\/14651858.CD011646.pub2-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD011646.pub2-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0006-2952(92)90561-V","article-title":"Antioxidant activity of propylthiouracil","volume":"43","author":"Hicks","year":"1992","journal-title":"Biochemical Pharmacology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0185|cit185","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Cochrane, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD011646.pub2-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: Concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0187|cit187","volume-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice CFR & ICH Guidelines","volume":"1","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"issue":"1","key":"10.1002\/14651858.CD011646.pub2-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2288-14-120","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Medical Research Methodology"},{"issue":"11","key":"10.1002\/14651858.CD011646.pub2-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"474","key":"10.1002\/14651858.CD011646.pub2-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1198\/016214505000001302","article-title":"Assessing evidence inconsistency in mixed treatment comparisons","volume":"101","author":"Lu","year":"2006","journal-title":"Journal of the American Statistical Association"},{"issue":"26","key":"10.1002\/14651858.CD011646.pub2-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011646.pub2-BIB0192|cit192","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub3","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD011646.pub2-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/sim.698","article-title":"A comparison of methods to detect publication bias in meta-analysis","volume":"20","author":"Macaskill","year":"2001","journal-title":"Statistics in Medicine"},{"issue":"12","key":"10.1002\/14651858.CD011646.pub2-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/2012.jama.11228","article-title":"How to use an article reporting a multiple treatment comparison meta-analysis","volume":"308","author":"Mills","year":"2012","journal-title":"JAMA"},{"issue":"9128","key":"10.1002\/14651858.CD011646.pub2-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0196|cit196","unstructured":"NCBI Liver diseases, alcoholic, 2014 www.ncbi.nlm.nih.gov\/mesh\/68008108"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0197|cit197","unstructured":"NCBI Fatty liver, 2014 www.ncbi.nlm.nih.gov\/mesh\/68005234"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0198|cit198","unstructured":"NCBI Hepatitis, alcoholic, 2014 www.ncbi.nlm.nih.gov\/mesh\/68006519"},{"issue":"5","key":"10.1002\/14651858.CD011646.pub2-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/ije\/21.5.837","article-title":"Intention-to-treat analysis: implications for quantitative and qualitative research","volume":"21","author":"Newell","year":"1992","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0200|cit200","unstructured":"NHS Choices Alcohol-related liver disease www.nhs.uk\/conditions\/liver_disease_(alcoholic)\/Pages\/Introduction.aspx"},{"issue":"1","key":"10.1002\/14651858.CD011646.pub2-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","article-title":"Alcoholic liver disease","volume":"51","author":"O'Shea","year":"2010","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0202|cit202","unstructured":"Members of OpenBUGS Project Management Group OpenBUGS 2014"},{"issue":"6","key":"10.1002\/14651858.CD011646.pub2-BIB0203|cit203","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001511.pub2","article-title":"Glucocorticosteroids for people with alcoholic hepatitis","author":"Pavlov","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0204|cit204","first-page":"g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"4","key":"10.1002\/14651858.CD011646.pub2-BIB0205|cit205","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003045.pub2","article-title":"Anabolic-androgenic steroids for alcoholic liver disease","author":"Rambaldi","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD011646.pub2-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1365-2036.2008.03685.x","article-title":"Systematic review: glucocorticosteroids for alcoholic hepatitis--a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials","volume":"27","author":"Rambaldi","year":"2008","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"11","key":"10.1002\/14651858.CD011646.pub2-BIB0207|cit207","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002235.pub3","article-title":"S-adenosyl-L-methionine for alcoholic liver diseases","author":"Rambaldi","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0208|cit208","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"4","key":"10.1002\/14651858.CD011646.pub2-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"2","key":"10.1002\/14651858.CD011646.pub2-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD011646.pub2-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1037","article-title":"Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool","volume":"3","author":"Salanti","year":"2012","journal-title":"Research Synthesis Methods"},{"issue":"35","key":"10.1002\/14651858.CD011646.pub2-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized controlled trials: combined analysis of meta-epidemiological studies","volume":"16","author":"Savovi\u0107","year":"2012","journal-title":"Health Technology Assessment"},{"issue":"6","key":"10.1002\/14651858.CD011646.pub2-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized controlled trials","volume":"157","author":"Savovi\u0107","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"9","key":"10.1002\/14651858.CD011646.pub2-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1111\/ajt.12384","article-title":"Twenty-year longitudinal follow-up after orthotopic liver transplantation: a single-center experience of 313 consecutive cases","volume":"13","author":"Schoening","year":"2013","journal-title":"American Journal of Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD011646.pub2-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"2","key":"10.1002\/14651858.CD011646.pub2-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.2517-6161.1993.tb01921.x","article-title":"Bayesian interval estimates which are also confidence intervals","volume":"55","author":"Severini","year":"1993","journal-title":"Journal of the Royal Statistical Society. Series B (Methodological)"},{"issue":"4","key":"10.1002\/14651858.CD011646.pub2-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1053\/j.gastro.2015.06.006","article-title":"Comparative effectiveness of pharmacological interventions for severe alcoholic hepatitis: a systematic review and network meta-analysis","volume":"149","author":"Singh","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0219|cit219","unstructured":"Scientific Registry of Transplant Recipients OPTN\/SRTR 2012 annual data report: liver, 2012 srtr.transplant.hrsa.gov\/annual_reports\/2012\/pdf\/03_liver_13.pdf"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0220|cit220","unstructured":"StataCorp LP Stata\/SE 14.2 for Windows[64-bit x86-64] 2017"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0221|cit221","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual for Trial Sequential Analysis (TSA). Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen, Denmark Available from www.ctu.dk\/tsa 2011 1 115"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0222|cit222","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/2046-4053-1-41","article-title":"Sample size and power considerations in network meta-analysis","volume":"1","author":"Thorlund","year":"2012","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0223|cit223","unstructured":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen TSA version 0.9 2011"},{"issue":"3","key":"10.1002\/14651858.CD011646.pub2-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/ije\/dys041","article-title":"Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews","volume":"41","author":"Turner","year":"2012","journal-title":"International Journal of Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD011646.pub2-BIB0225|cit225","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/jrsm.1054","article-title":"Automating network meta-analysis","volume":"3","author":"Valkenhoef","year":"2012","journal-title":"Research synthesis methods"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0226|cit226","unstructured":"Ware JE SF-36\u00ae health survey update, 2014 www.sf-36.org\/tools\/sf36.shtml"},{"issue":"1","key":"10.1002\/14651858.CD011646.pub2-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial Sequential Analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD011646.pub2-BIB0228|cit228","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial Sequential Analysis in systematic reviews with meta-analysis","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Medical Research Methodology"},{"issue":"4","key":"10.1002\/14651858.CD011646.pub2-BIB0229|cit229","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007339.pub2","article-title":"Pentoxifylline for alcoholic hepatitis","author":"Whitfield","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0230|cit230","unstructured":"World Health Organization - Regional Office for Europe Status report on alcohol and health in 35 European countries 2013 www.euro.who.int\/__data\/assets\/pdf_file\/0017\/190430\/Status-Report-on-Alcohol-and-Health-in-35-European-Countries.pdf?ua=1"},{"key":"10.1002\/14651858.CD011646.pub2-BIB0231|cit231","unstructured":"World Health Organization Global status report on alcohol and health 2014 http:\/\/apps.who.int\/iris\/bitstream\/10665\/112736\/1\/9789240692763_eng.pdf 2014"},{"issue":"7644","key":"10.1002\/14651858.CD011646.pub2-BIB0232|cit232","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"9","key":"10.1002\/14651858.CD011646.pub2-BIB0233|cit233","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/liv.12553","article-title":"Liver transplantation: a systematic review of long-term quality of life","volume":"34","author":"Yang","year":"2014","journal-title":"Liver International"},{"issue":"4","key":"10.1002\/14651858.CD011646.pub2-BIB0234|cit234","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011646","article-title":"Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease): a network meta-analysis","author":"Gurusamy","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD011646.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T09:55:03Z","timestamp":1683194103000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011646.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,31]]},"references-count":234,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011646.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,31]]}}}